Veracyte Announces Publication of Study Showcasing Development of Percepta™ Bronchial Genomic Classifier
May 12, 2015Veracyte's study on the derivation of the company's Percepta Bronchial Genomic Classifier, which is used to help patients avoid unnecessary invasive procedures as part of lung cancer diagnosis, is published in BMC Genomics.
More »
aTyr Pharma, Inc. Announces Closing of Initial Public Offering
May 12, 2015aTyr announces the closing of its initial public offering of 6,164,000 shares of its common stock at an initial public offering price of $14.00 per share, before underwriting discounts, including 804,000 shares of common stock.
More »
Aldeyra Therapeutics Announces Pricing of Follow-On Public Offering of Common Stock
May 8, 2015Aldeyra Therapeutics announces the pricing of its follow-on public offering of 2,700,000 shares of its common stock at $7.50 per share and has granted the underwriters a 30-day option to purchase up to an additional 405,000 shares of common stock.
More »